ESTIMATED COST OF BUPIVACAINE LIPOSOMAL INJECTABLE SUSPENSION IN MEDICARE PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY USING PREMIER CHARGEMASTER DATA
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1134
https://www.valueinhealthjournal.com/article/S1098-3015(16)01202-X/fulltext
Section Title :
Muscular-Skeletal Disorders - Cost Studies
Section Order :
808
First Page :
A230
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01202-X&doi=10.1016/j.jval.2016.03.1134